Clinical trial
Phase 4 Study - Mucinex D as Adjunct Therapy
NCT00441246 · Adams Respiratory Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00441246 |
|---|---|
| Title | Phase 4 Study - Mucinex D as Adjunct Therapy |
| Official title | A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection |
| Lead sponsor | Adams Respiratory Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Respiratory Infection, Bronchitis, Rhinosinusitis |
| Intervention type | Drug |
| Interventions | Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets) |
| Enrollment | 600 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 28, 2007 |
| Last update posted | Feb 6, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: